Bahceci Health Group, Fulya Istanbul, Turkey.
Bahceci Health Group, Fulya Istanbul, Turkey.
Reprod Biomed Online. 2021 Apr;42(4):733-741. doi: 10.1016/j.rbmo.2021.01.001. Epub 2021 Jan 8.
Does an association exist between ovarian reserve, ovarian response and embryonic euploidy in female patients under age 35 years?
This was a retrospective analysis of intracytoplasmic sperm injection and preimplantation genetic testing for aneuploidies cycles among patients enrolled at Bahceci Fulya IVF Center between January 2016 and August 2019. A total of 133 patients in POSEIDON group 1 (suboptimal responder; female age <35 years, antral follicle count [AFC] ≥5, number of oocytes retrieved <10) (group A), 133 patients in POSEIDON group 3 (expected low responder; female age <35 years, AFC <5) (group B) and 323 in the non-low-prognosis group (female age <35 years, AFC ≥5 and number of oocytes retrieved >9) (group C) were included.
There was no significant difference in euploidy rate per embryo among the three groups (61.7% [145/235] for group A versus 53.5% [68/127] for group B versus 62% [625/1008] for group C; P = 0.13). The cancellation rate in cycles without a euploid blastocyst was significantly lower in group C than groups A and B (8.4% versus 12.8% and 16.5%; P = 0.034). Multivariate regression analysis indicated that the ovarian response group did not significantly affect the probability of obtaining a euploid embryo. Trophectoderm score 'C' (odds ratio 0.520, P = 0.007) and inner cell mass score 'C' (odds ratio 0.480, P < 0.001) were associated with a decreased probability of obtaining a euploid embryo.
These results confirm that POSEIDON group 1 and group 3 and non-low-prognosis patients have different probabilities of euploid embryos being obtained per cycle. However, euploidy rates per embryo are not affected by the patient's ovarian reserve and response.
在年龄<35 岁的女性患者中,卵巢储备、卵巢反应和胚胎整倍体之间是否存在关联?
这是对 2016 年 1 月至 2019 年 8 月在 Bahceci Fulya IVF 中心接受胞浆内单精子注射和植入前胚胎遗传学检测的患者的回顾性分析。共纳入 133 名 POSEIDON 1 组(低反应者;年龄<35 岁,窦卵泡计数[AFC]≥5,获卵数<10)(A 组)、133 名 POSEIDON 3 组(预期低反应者;年龄<35 岁,AFC<5)(B 组)和 323 名非低预后组(年龄<35 岁,AFC≥5,获卵数>9)(C 组)。
三组胚胎整倍体率无显著差异(A 组 145/235,61.7%;B 组 68/127,53.5%;C 组 625/1008,62%;P=0.13)。无整倍体囊胚的周期取消率在 C 组显著低于 A 组和 B 组(8.4%比 12.8%和 16.5%;P=0.034)。多变量回归分析表明,卵巢反应组并不显著影响获得整倍体胚胎的概率。滋养外胚层评分“C”(比值比 0.520,P=0.007)和内细胞团评分“C”(比值比 0.480,P<0.001)与获得整倍体胚胎的概率降低相关。
这些结果证实,POSEIDON 1 组和 3 组和非低预后患者的每个周期获得整倍体胚胎的概率不同。然而,胚胎的整倍体率不受患者卵巢储备和反应的影响。